Literature DB >> 9681583

Clinical features of circadian rhythm sleep disorders in outpatients.

W Yamadera1, M Sasaki, H Itoh, M Ozone, S Ushijima.   

Abstract

The clinical data of 86 cases of primary circadian rhythm sleep disorder (primary CRSD) were retrospectively examined and compared to 40 cases of secondary circadian rhythm sleep disorder (secondary CRSD), who had presented with some kind of psychiatric or medical disorder, and had exhibited sleep-wake rhythm disorders that were judged to be secondary CRSD based on sleep logs. The comparison of cases found that: (i) the mean age at first presentation to the clinic was significantly younger for primary CRSD compared to secondary CRSD; (ii) more secondary CRSD cases were unemployed than were Primary CRSD cases; (iii) more cases in the secondary CRSD group had a clear trigger for sleep-wake rhythm disorder onset than cases in the primary CRSD group; and (iv) the types of sleep-wake rhythm disorders in the primary CRSD group consisted of delayed sleep phase syndrome (DSPS), 72 (83.7%), non-24 pattern, 11 (12.8%), and irregular, 3 (3.5%). In the secondary CRSD group there were 25 (62.5%) cases of DSPS pattern, 1 (2.5%) of non-24 pattern and 14 (35.0%) with irregular pattern. The 56 (65.1%) cases with primary CRSD showed good response to vitamin B12 and bright light therapy; however, 28 (70.0%) cases with secondary CRSD did not respond to such therapies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681583     DOI: 10.1046/j.1440-1819.1998.00395.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  8 in total

1.  Circadian rhythm sleep disorder, free-running type in a sighted male with severe depression, anxiety, and agoraphobia.

Authors:  Mark A Brown; Stuart F Quan; Philip S Eichling
Journal:  J Clin Sleep Med       Date:  2011-02-15       Impact factor: 4.062

2.  Systematic evaluation of Axis-I DSM diagnoses in delayed sleep phase disorder and evening-type circadian preference.

Authors:  Kathryn J Reid; Ashley A Jaksa; Julie B Eisengart; Kelly G Baron; Brandon Lu; Peter Kane; Joseph Kang; Phyllis C Zee
Journal:  Sleep Med       Date:  2012-08-19       Impact factor: 3.492

Review 3.  Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review.

Authors:  Robert L Sack; Dennis Auckley; R Robert Auger; Mary A Carskadon; Kenneth P Wright; Michael V Vitiello; Irina V Zhdanova
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

Review 4.  Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review.

Authors:  Robert L Sack; Dennis Auckley; R Robert Auger; Mary A Carskadon; Kenneth P Wright; Michael V Vitiello; Irina V Zhdanova
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

5.  Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT1 receptor as well as BDNF expression in the hippocampus during the subjective light phase of rats exposed to chronic constant light.

Authors:  Jana Tchekalarova; Lidia Kortenska; Natasha Ivanova; Milena Atanasova; Pencho Marinov
Journal:  Psychopharmacology (Berl)       Date:  2019-11-13       Impact factor: 4.530

Review 6.  Behavioral and psychiatric consequences of sleep-wake schedule disorders.

Authors:  Yaron Dagan; Katy Borodkin
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

7.  Decrease in Social Zeitgebers Is Associated With Worsened Delayed Sleep-Wake Phase Disorder: Findings During the Pandemic in Japan.

Authors:  Rei Otsuki; Kentaro Matsui; Takuya Yoshiike; Kentaro Nagao; Tomohiro Utsumi; Ayumi Tsuru; Naoko Ayabe; Megumi Hazumi; Michio Fukumizu; Kenichi Kuriyama
Journal:  Front Psychiatry       Date:  2022-06-09       Impact factor: 5.435

8.  Non-24-hour sleep-wake disorder successfully treated with the combination of ramelteon and suvorexant in a case of autism spectrum disorder.

Authors:  Masaaki Iwata; Koichi Kaneko
Journal:  Neuropsychopharmacol Rep       Date:  2020-09-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.